Clinical High Risk for Psychosis Clinical Trial
Official title:
Gabapentin in Patients at Clinical Risk for Psychosis
The purpose of this study is to test the effects of the drug gabapentin on brain function thought to be important in the development of schizophrenia. Researchers think that treating a brain region with gabapentin (the hippocampus) may reduce the risk for developing schizophrenia.
Six week, single site, proof-of concept, randomized double-blind placebo-controlled pilot study to examine the effects of moderate dose gabapentin (3600mg) in n= 100 putatively prodromal patients on hippocampal activity. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03829527 -
Evaluation of the Treatment Approach ROBIN
|
N/A | |
| Recruiting |
NCT05827900 -
Metacognitive Training in Ultra-high Risk
|
N/A | |
| Recruiting |
NCT02951208 -
tDCS Coupled With Virtual Rehabilitation for Negative Symptoms in At-Risk Youth
|
N/A | |
| Completed |
NCT03983421 -
Feasibility of an Early Detection Program for Early Psychosis on a College Campus
|
||
| Recruiting |
NCT06037993 -
Endocannabinoid Activity Remodulation for Psychosis Liability in Youth
|
N/A | |
| Completed |
NCT02404194 -
Targeted Cognitive Training in Clinical High Risk (CHR) for Psychosis
|
N/A | |
| Completed |
NCT04444180 -
The Predictive Role of Self-representation in Transition of Individuals at Clinical High Risk for Psychosis
|
||
| Terminated |
NCT02047539 -
Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis
|
Early Phase 1 | |
| Recruiting |
NCT05114733 -
Individualized Vocational and Educational Support and Training for Clinical High Risk for Psychosis (InVEST)
|
N/A | |
| Completed |
NCT03303456 -
Using Mobile Technology to Enhance Early Psychosis Treatment Delivery
|
N/A | |
| Completed |
NCT03286595 -
Smartphone Applications Youth With Early Psychosis in Community Outpatient Settings
|
N/A | |
| Completed |
NCT03321617 -
Glutamate Reducing Interventions in Schizophrenia
|
Phase 1 |